Menu
Montecito
PacPremier
Loading...
You are here:  Home  >  Biotech  >  Current Article

Atara Biotherapeutics raises $175 million

By   /   Friday, June 5th, 2020  /   Comments Off on Atara Biotherapeutics raises $175 million

    Print       Email
Fresh off the release of new data in its multiple sclerosis program, Atara Biotherapeutics added $175 million to its coffers as it gears up to take its primary product to market. A clinical study of its MS therapy ATA188 released both promising safety data and early evidence that it could improve disability in patients. Just…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Henry Dubroff

Dubroff: U.S. Bank’s big buy revives long-simmering rivalry with Wells Fargo

Read More →